Genetic Carrier Screening: Increasing Opportunities, Increasing Challenges

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 12/5/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.75
Description:

Faculty

Marisa Vineyard Andrews, MS
Genetic Counselor, Obstetrics & Gynecology
Fertility and Reproductive Medicine Center
Financial Disclosures
Consulting/Advisory Committees: Mallinckrodt Pharmaceuticals

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 45th Annual Symposium on Obstetrics & Gynecology, October 3-4, 2019, which was supported in part by Cook Medical.

Planning Committee

Crystal J. Carroll, RN, BSN
Nurse Coordinator
Financial Disclosures: Nothing to disclose

Randall R. Odem, MD
Professor of Obstetrics and Gynecology
Division of Reproductive Endocrinology and Infertility
Financial Disclosures: Nothing to disclose
Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Define genetic carrier screening
  • Relate the professional guidelines for genetic carrier screening
  • Compare and contrast options for genetic carrier screening
  • Explain the benefits and applications of genetic carrier screening for patient care
  • Recognize the limitations and risks of genetic carrier screening
  • Identify patients who may benefit from genetic counseling and/or additional genetic testing
Additional Information:
Target Audience: This course is designed for obstetricians and gynecologists, subspecialties of reproductive endocrinology and infertility, maternal fetal medicine, gynecologic oncology, urogynecology, pediatric and adolescent gynecology, family planning, primary care physicians, as well as physicians in training, nurse practitioners, nurses and allied health professionals that care for obstetrics and gynecology patients.

Publication Date: December 5, 2019
Expiration Date: June 30, 2020
Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.
References:
  • https://s3-us-west-2.amazonaws.com/sema4genomics-com-wordpress-uploads/wp-content/uploads/Sema4_Carrier-Screen-Residual-Risk_v01.pdf
  • Blythe AS, Farrell PM. Advances in the diagnosis and management of cystic fibrosis. Clin Biochem. 1984;17(5)277-283.
  • Capalbo, A et al. Should the reproductive risk of a couple aiming to conceive be tested in the contemporary clinical context?. Fertil Steril. 2019;111(2):229-238.
  • Committee on Genetics. Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017;129(3):e35-e40.
  • Committee on Genetics. Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol. 2017;129(3):e41-e55.
  • Edwards JG et al. Expanded carrier screening in reproductive medicine – points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol. 2015;125(3):653-662.
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Categories: Nurse, OBGYN


Powered By AI 4.5